Compound class:
Synthetic organic
Comment: EG-001's chemical structure was derived from that of the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib [1], but it does not inhibit BTK or any other kinase. It has potent anti-proliferative and anti-tumour effects in vivo, against a wide range of lymphomas and leukaemias. A preprint has reported the molecular mechanism of EG-001 [2]; it acts to convert the auto-inhibited (closed) form of the Wiskott-Aldrich syndrome protein (WASp; WAS; P42768) to its activated allosteric conformation. WASp is one of a family of actin/cytoskeleton-regulating proteins that is expressed only in cells of haematopoietic origin. Activated WASp increases actin polymerisation (via interactions with the Arp2/3 complex), induces cytoskeleton reorganisation, and promotes cell death.
|
|
For advanced searching click here to open chemical structure editor
Similar Ligands ![]() |
|||||||
|
|
||||||
|